Concern regarding classification of germline TP53 variants as likely pathogenic

被引：5
|
作者：
Evans, D. Gareth [1 ,2 ,3 ]
Turnbull, Clare [4 ,5 ]
Woodward, Emma R. [1 ,2 ,3 ]
机构：
[1] Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Manchester, Lancs, England
[2] Manchester Univ Hosp NHS Fdn Trust, NW Lab Genet Hub, Manchester, Lancs, England
[3] Univ Manchester, Hlth Innovat Manchester, Fac Biol Med & Hlth, Div Evolut & Genom Sci,Sch Biol Sci, Manchester, Lancs, England
[4] Inst Canc Res, Div Genet & Epidemiol, London, England
[5] Queen Mary Univ London, William Harvey Res Inst, Dept Canc Genet, London, England
来源：
HUMAN MUTATION | 2019年 / 40卷 / 06期
关键词：
CANCER;
D O I：
10.1002/humu.23750
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：828 / 831
页数：4
相关论文
共 50 条
  • [1] Response to: Concern regarding classification of germlineTP53 variants as likely pathogenic
    de Andrade, Kelvin C.
    Frone, Megan N.
    Wegman-Ostrosky, Talia
    Khincha, Payal P.
    Kim, Jung
    Amadou, Amina
    Santiago, Karina M.
    Fortes, Fernanda P.
    Lemonnier, Nathanael
    Mirabello, Lisa
    Stewart, Douglas R.
    Hainaut, Pierre
    Kowalski, Luiz P.
    Savage, Sharon A.
    Achatz, Maria I.
    HUMAN MUTATION, 2019, 40 (06) : 832 - 833
  • [2] Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants
    de Andrade, Kelvin C.
    Strande, Natasha T.
    Kim, Jung
    Haley, Jeremy S.
    Hatton, Jessica N.
    Frone, Megan N.
    Khincha, Payal P.
    Thone, Gretchen M.
    Mirshahi, Uyenlinh L.
    Schneider, Cynthia
    Desai, Heena
    Dove, James T.
    Smelser, Diane T.
    Penn Med Biobank, Penn Medicine
    Regeneron Genetics, Arnold J.
    Levine, Arnold J.
    Maxwell, Kara N.
    Stewart, Douglas R.
    Carey, David J.
    Savage, Sharon A.
    HUMAN GENETICS AND GENOMICS ADVANCES, 2024, 5 (01):
  • [3] Germline TP53 pathogenic variants and breast cancer: A narrative review
    Blondeaux, Eva
    Arecco, Luca
    Punie, Kevin
    Graffeo, Rossella
    Toss, Angela
    De Angelis, Carmine
    Trevisan, Lucia
    Buzzatti, Giulia
    Linn, Sabine C.
    Dubsky, Peter
    Cruellas, Mara
    Partridge, Ann H.
    Balman, Judith
    Paluch-Shimon, Shani
    Lambertini, Matteo
    CANCER TREATMENT REVIEWS, 2023, 114
  • [4] TP53 germline pathogenic variants in modern humans were likely originated during recent human history
    Kou, Si Hoi
    Li, Jiaheng
    Tam, Benjamin
    Lei, Huijun
    Zhao, Bojin
    Xiao, Fengxia
    Wang, San Ming
    NAR CANCER, 2023, 5 (03):
  • [5] Genome-first approach to characterize the prevalence and associated cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants
    De Andrade, Kelvin Cesar
    Strande, Natasha T.
    Kim, Jung
    Haley, Jeremy S.
    Hatton, Jessica N.
    Frone, Megan N.
    Khincha, Payal P.
    Thone, Gretchen M.
    Mirshahi, Uyenlinh L.
    Schneider, Cynthia
    Desai, Heena
    Dove, James T.
    Smelser, Diane T.
    Levine, Arnold J.
    Maxwell, Kara N.
    Stewart, Douglas
    Carey, David J.
    Savage, Sharon A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 576 - 577
  • [6] Germline TP53 Variants and Susceptibility to Osteosarcoma
    Mirabello, Lisa
    Yeager, Meredith
    Mai, Phuong L.
    Gastier-Foster, Julie M.
    Gorlick, Richard
    Khanna, Chand
    Patino-Garcia, Ana
    Sierrasesumaga, Luis
    Lecanda, Fernando
    Andrulis, Irene L.
    Wunder, Jay S.
    Gokgoz, Nalan
    Barkauskas, Donald A.
    Zhang, Xijun
    Vogt, Aurelie
    Jones, Kristine
    Boland, Joseph F.
    Chanock, Stephen J.
    Savage, Sharon A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (07):
  • [7] Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study
    Cesar de Andrade, Kelvin
    Khincha, Payal P.
    Hatton, Jessica N.
    Frone, Megan N.
    Wegman-Ostrosky, Talia
    Mai, Phuong L.
    Best, Ana F.
    Savage, Sharon A.
    LANCET ONCOLOGY, 2021, 22 (12): : 1787 - 1798
  • [8] Pathogenic germline variants of TP53 gene are rare in patients with chronic lymphocytic leukemia
    Pavlova, Sarka
    Malcikova, Jitka
    Gombikova, Johana
    Smardova, Jana
    Plevova, Karla
    Kotaskova, Jana
    Dvorackova, Barbara
    Vonkova, Barbara Kunt
    Zavacka, Kristyna
    Navrkalova, Veronika
    Trizuljak, Jakub
    Doubek, Michael
    Pospisilova, Sarka
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 542 - 543
  • [9] The Broad Spectrum of TP53 Variants in CLL: NGS Analysis of 573 Pathogenic TP53 Variants
    Lazarian, Gregory
    Theves, Floriane
    Hormi, Myriam
    Eclache, Virginie
    Poulain, Stephanie
    Bidet, Audrey
    Pastoret, Cedric
    Veronese, Lauren
    Delabesse, Eric
    Estienne, Marie-Helene
    Nadal, Nathalie
    Davi, Frederic
    Nguyen-Khac, Florence
    Lode, Laurence
    Sujobert, Pierre
    Naguib, Dina
    Raynaud, Sophie
    Giraudier, Stephane
    Kosmider, Olivier
    Etancelin, Pascaline
    Cornillet-Lefebvre, Pascale
    Miguet, Laurent
    Leblond, Veronique
    Letestu, Remi
    Soussi, Thierry
    Cymbalista, Florence
    Baran-Marszak, Fanny
    BLOOD, 2019, 134
  • [10] TP53 pathogenic variants with low allele fraction in germline genetic testing.
    Wu, Yanqing
    Fan, Wenzhe
    Xue, Miao
    Tang, Yiyang
    Peisu, Suo
    Yang, Bo
    Huang, Tanxiao
    Zhang, Jing
    Li, Jiaping
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345